Amedeo's Top 20

Amedeo Smart

Independent Medical Education

04 May 2015

Multidisciplinary Journal Club

  1. Diaz E , Martin-Loeches I, Canadell L, Vidaur L, et al.
    Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza.
    J Infect 2012.

  1. Kalia LV, Lang AE.
    Parkinson's disease.
    Lancet 2015.

  2. Robert C, Schachter J, Long GV, Arance A, et al.
    Pembrolizumab versus Ipilimumab in Advanced Melanoma.
    N Engl J Med 2015.

  3. Postow MA, Chesney J, Pavlick AC, Robert C, et al.
    Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma.
    N Engl J Med 2015.

  4. Garon EB, Rizvi NA, Hui R, Leighl N, et al.
    Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer.
    N Engl J Med 2015.

  1. Radford J, Illidge T, Counsell N, Hancock B, et al.
    Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.
    N Engl J Med 2015;372:1598-607.

  2. Lamb SE, Williamson EM, Heine PJ, Adams J, et al.
    Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial.
    Lancet 2015;385:421-9.

  3. Rapp SR, Case LD, Peiffer A, Naughton MM, et al.
    Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial.
    J Clin Oncol 2015.

  4. .
    Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial.
    Lancet 2015.

  5. Tan GS, Lee PS, Hoffman RM, Mazel-Sanchez B, et al.
    Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin.
    J Virol 2014.

  1. Ye S, Lowther S, Stambas J.
    Inhibition of reactive oxygen species production ameliorates inflammation induced by influenza A viruses via up-regulation of SOCS1 and SOCS3.
    J Virol 2014.

  2. Huang Y, Chen Z, Huang J, Fu Z, et al.
    Parainfluenza virus 5 expressing the G protein of rabies virus protected mice after rabies virus infection.
    J Virol 2014.

  3. Chapman PB, D'Angelo SP, Wolchok JD.
    Rapid Eradication of a Bulky Melanoma Mass with One Dose of Immunotherapy.
    N Engl J Med 2015.

  4. Joseph U, Linster M, Suzuki Y, Krauss S, et al.
    Adaptation of Pandemic H2N2 Influenza A Viruses in Humans.
    J Virol 2014.

  5. Sax PE, Wohl D, Yin MT, Post F, et al.
    Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.
    Lancet 2015.

  1. Gettinger SN, Horn L, Gandhi L, Spigel DR, et al.
    Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol 2015.

  2. Jain A, Marshall J, Buikema A, Bancroft T, et al.
    Autism occurrence by MMR vaccine status among US children with older siblings with and without autism.
    JAMA 2015;313:1534-40.

  3. Bhatt AG, Monahan KM.
    Fitness and the Development of Atrial Fibrillation.
    Circulation 2015.

  4. Advani RH, Hong F, Fisher RI, Bartlett NL, et al.
    Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.
    J Clin Oncol 2015.

  5. Thursz MR, Richardson P, Allison M, Austin A, et al.
    Prednisolone or pentoxifylline for alcoholic hepatitis.
    N Engl J Med 2015;372:1619-28.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016